The Enterprise Value as of November 2024 (TTM) for Esperion Therapeutics, Inc. (ESPR) is 759.78M

According to Esperion Therapeutics, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 759.78M. This represents a change of 14.37% compared to the average of 664.33M of the last 4 quarters.

Esperion Therapeutics, Inc. (ESPR) Historical Enterprise Value (quarterly & annually)

How has ESPR Enterprise Value performed in the past?

The mean historical Enterprise Value of Esperion Therapeutics, Inc. over the last ten years is 754.04M. The current 759.78M Enterprise Value has changed 9.98% with respect to the historical average. Over the past ten years (40 quarters), ESPR's Enterprise Value was at its highest in in the March 2018 quarter at 1.89B. The Enterprise Value was at its lowest in in the June 2016 quarter at 177.47M.

Esperion Therapeutics, Inc. (ESPR) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Esperion Therapeutics, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Esperion Therapeutics, Inc. (ESPR) Average Enterprise Value

How has ESPR Enterprise Value performed in the past?

The current Enterprise Value of Esperion Therapeutics, Inc. (ESPR) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Esperion Therapeutics, Inc. (ESPR) Enterprise Value vs. Peers

How is ESPR’s Enterprise Value compared to its peers?

Esperion Therapeutics, Inc.’s Enterprise Value is less than Elanco Animal Health Incorporated (11.47B), greater than SIGA Technologies, Inc. (394.26M), less than Indivior PLC (1.13B), less than Catalent, Inc. (15.35B), greater than Eagle Pharmaceuticals, Inc. (16.86M), less than ANI Pharmaceuticals, Inc. (1.25B), less than Phibro Animal Health Corporation (1.36B), less than Deciphera Pharmaceuticals, Inc. (2.15B), less than Prestige Consumer Healthcare Inc. (4.73B), less than Collegium Pharmaceutical, Inc. (1.44B), less than Pacira BioSciences, Inc. (1.16B), less than Intra-Cellular Therapies, Inc. (8.69B), less than Alkermes plc (4.19B), less than Neurocrine Biosciences, Inc. (12.11B), less than Ironwood Pharmaceuticals, Inc. (1.20B), less than Avadel Pharmaceuticals plc (1.44B), greater than Lifecore Biomedical, Inc. (343.00M), greater than Rockwell Medical, Inc. (123.22M), greater than Kamada Ltd. (296.47M), greater than Agile Therapeutics, Inc. (7.87M),

Build a custom stock screener for Esperion Therapeutics, Inc. (ESPR) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Esperion Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Esperion Therapeutics, Inc. (ESPR) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Esperion Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.